1. Home
  2. ATEC vs PCRX Comparison

ATEC vs PCRX Comparison

Compare ATEC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEC
  • PCRX
  • Stock Information
  • Founded
  • ATEC 1990
  • PCRX 2006
  • Country
  • ATEC United States
  • PCRX United States
  • Employees
  • ATEC N/A
  • PCRX N/A
  • Industry
  • ATEC Medical/Dental Instruments
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATEC Health Care
  • PCRX Health Care
  • Exchange
  • ATEC Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • ATEC 1.3B
  • PCRX 1.2B
  • IPO Year
  • ATEC 2006
  • PCRX 2011
  • Fundamental
  • Price
  • ATEC $10.61
  • PCRX $25.16
  • Analyst Decision
  • ATEC Strong Buy
  • PCRX Buy
  • Analyst Count
  • ATEC 10
  • PCRX 9
  • Target Price
  • ATEC $17.50
  • PCRX $26.22
  • AVG Volume (30 Days)
  • ATEC 1.4M
  • PCRX 805.4K
  • Earning Date
  • ATEC 02-26-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • ATEC N/A
  • PCRX N/A
  • EPS Growth
  • ATEC N/A
  • PCRX N/A
  • EPS
  • ATEC N/A
  • PCRX N/A
  • Revenue
  • ATEC $572,739,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • ATEC $28.51
  • PCRX $5.55
  • Revenue Next Year
  • ATEC $20.37
  • PCRX $5.64
  • P/E Ratio
  • ATEC N/A
  • PCRX N/A
  • Revenue Growth
  • ATEC 27.21
  • PCRX 4.40
  • 52 Week Low
  • ATEC $4.88
  • PCRX $11.16
  • 52 Week High
  • ATEC $15.69
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • ATEC 45.32
  • PCRX 52.48
  • Support Level
  • ATEC $10.66
  • PCRX $25.41
  • Resistance Level
  • ATEC $11.17
  • PCRX $26.89
  • Average True Range (ATR)
  • ATEC 0.42
  • PCRX 1.18
  • MACD
  • ATEC -0.15
  • PCRX -0.36
  • Stochastic Oscillator
  • ATEC 9.44
  • PCRX 4.35

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: